People over the age of 65 are at high risk. The drug adverse reaction monitoring report will be released in 2025.

Today, the reporter learned from the National Medical Products Administration that the latest "National Drug Adverse Reaction Monitoring 2025 Annual Report" has been released. The report shows that in 2025, China received over 2.7 million reports of drug adverse reactions, an increase of over 5% compared to the previous year. The report on drug adverse reaction events in 2025 shows that patients aged 65 and older are at high risk, accounting for more than one-third of the reports. Monitoring suggests that clinical efforts should continue to strengthen the safe drug management of elderly patients. The proportion of child patients is relatively low, with overall good safety and relatively safe.